Enteris BioPharma offers innovative formulation solutions built around its proprietary oral delivery technology platform – Peptelligence®. Since its founding in 2013, Enteris BioPharma has advanced multiple internal and external programs leveraging its Peptelligence® platform. The technology has been developed and proven effective to enable the safe delivery of peptide-based therapeutics and other molecules with low oral bioavailability.

Enteris BioPharma white oral drug delivery tablets

PEPTELLIGENCE®

Enteris BioPharma offers Intelligent Solutions for Oral Drug Delivery of peptides and BCS Class II, Class III and Class IV compounds in an enteric-coated tablet.

LEARN MORE
Enteris BioPharma three women smiling

PIPELINE

Enteris BioPharma internal pipeline of products for women’s health are being evaluated and include Ovarest® for endometriosis and Tobrate™ for uUTIs.

LEARN MORE
Enteris BioPharma two businessmen's hands about to shake in partnership

PARTNERING

Enteris BioPharma builds long-term relationships, with proven clinical stage biopharmaceutical oral peptide drug delivery solutions in novel formulations.

LEARN MORE
Enteris BioPharma scientist in full PPE monitoring gauges of equipment

ABOUT US

Enteris BioPharma is a privately held, clinical stage biopharmaceutical company in NJ with formulation solutions via proprietary oral peptide delivery technologies.

LEARN MORE

NEWS & EVENTS

Enteris, KeyBioscience to Develop Solutions for Metabolic Disorders Ferring, Enteris to Develop Oral Peptide Therapeutic

LEARN MORE
 

DOWNLOADS

PEPTELLIGENCE® BROCHURE
CORPORATE OVERVIEW PRESENTATION
 

CONTACT US